Osteoporosis
Studies from Belgium, and Novartis has received CHMP advice on the Phase III trial design and clearance from FDA to proceed with Phase III study under a special protocol assessment have provided new osteoporosis data
Published in Health Risk Factor Week, August 28th, 2007
Study 1: According to recent research from Liege, Belgium, "As reduced pain and disability. The unique mechanism of action of strontium ranelate corrects bone turnover so that it is rebalanced in favor of bone formation."
"Double-blind, placebo-controlled studies in postmenopausal osteoporosis show it to be effective in reducing vertebral and hip fracture risks. Treatment efficacy has been documented across a wide range of patient profiles...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Aspergillosis
Studies from P. Kayiran and colleagues provide new data on aspergillosis - B-Cell Lymphoma
Study data from University of Leipzig, Department of Pediatrics update knowledge of B-cell lymphoma in children - Bacteremia Epidemiology
Research in the area of bacteremia epidemiology reported from E. Siebor and colleagues - Bacterial Meningitis Therapy
Research from Charite University, Department of Neurology in bacterial meningitis therapy provides new insights - Behavior
UCLA develops new model to predict the spread of a 'super-bug' in L.A. county jail - Bioengineering
Research from Princeton University, Department of Molecular Biology has provided new data on bioengineering - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
